HomeCompareTPIA vs JNJ

TPIA vs JNJ: Dividend Comparison 2026

TPIA yields 10526.32% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TPIA wins by $91421458538285344.00M in total portfolio value
10 years
TPIA
TPIA
● Live price
10526.32%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$91421458538285344.00M
Annual income
$89,744,322,218,307,970,000,000.00
Full TPIA calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TPIA vs JNJ

📍 TPIA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTPIAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TPIA + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TPIA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TPIA
Annual income on $10K today (after 15% tax)
$894,736.84/yr
After 10yr DRIP, annual income (after tax)
$76,282,673,885,561,770,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TPIA beats the other by $76,282,673,885,561,770,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TPIA + JNJ for your $10,000?

TPIA: 50%JNJ: 50%
100% JNJ50/50100% TPIA
Portfolio after 10yr
$45710729269142672.00M
Annual income
$44,872,161,109,153,986,000,000.00/yr
Blended yield
98.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TPIA
No analyst data
Altman Z
-22.4
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TPIA buys
0
JNJ buys
0
No recent congressional trades found for TPIA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTPIAJNJ
Forward yield10526.32%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$91421458538285344.00M$20.0K
Annual income after 10y$89,744,322,218,307,970,000,000.00$827.78
Total dividends collected$91309952364754128.00M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TPIA vs JNJ ($10,000, DRIP)

YearTPIA PortfolioTPIA Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,063,332$1,052,631.58$10,676$355.77+$1.05MTPIA
2$105,744,905$104,607,140.08$11,407$389.39+$105.73MTPIA
3$9,835,430,757$9,722,283,708.79$12,198$426.53+$9835.42MTPIA
4$855,644,041,989$845,120,131,078.84$13,056$467.62+$855644.03MTPIA
5$69,627,827,846,009$68,712,288,721,080.95$13,987$513.12+$69627827.83MTPIA
6$5,300,152,192,813,391$5,225,650,417,018,161.00$14,998$563.56+$5300152192.80MTPIA
7$377,430,657,448,967,200$371,759,494,602,656,830.00$16,098$619.52+$377430657448.95MTPIA
8$25,145,413,383,015,215,000$24,741,562,579,544,820,000.00$17,295$681.69+$25145413383015.20MTPIA
9$1,567,417,121,474,185,500,000$1,540,511,529,154,359,300,000.00$18,599$750.82+$1567417121474185.50MTPIA
10$91,421,458,538,285,340,000,000$89,744,322,218,307,970,000,000.00$20,022$827.78+$91421458538285344.00MTPIA

TPIA vs JNJ: Complete Analysis 2026

TPIAStock

Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, severe anxiety, depression, palliative care, and serotonin syndrome. The company is based in Aventura, Florida. Mycotopia Therapies, Inc. is a subsidiary of EHAVE, Inc.

Full TPIA Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TPIA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TPIA vs SCHDTPIA vs JEPITPIA vs OTPIA vs KOTPIA vs MAINTPIA vs ABBVTPIA vs MRKTPIA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.